Scarab Genomics and Lonza have entered into a preferred marketing and sales agreement for Scarab Genomics’ Clean Genome(r) E. coli. Financial details of the contract were not disclosed. Lonza will support Scarab Genomics’ business development activities and becomes the preferred marketing provider for the Clean Genome technology, giving Lonza customers full access to the platform for protein and plasmid DNA production. Additionally, Lonza and Scarab Genomics will work together to ...